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In this case control study, long‑term gynecological, reproductive and sexual outcomes after uterine 
artery embolization (UAE) for postpartum hemorrhage (PPH) were evaluated. The study was 
performed in a single referral hospital for PPH in Lausanne from 2003 to 2013. Each woman whose 
delivery was complicated by PPH and treated by UAE was included, and compared to a control group 
of women whose delivery was uncomplicated. Cases were matched by maternal age, parity, ethnicity, 
year and mode of delivery, birth weight and gestational age in a 1–3 ratio. A total of 77 patients 
treated by UAE for PPH were identified in our obstetrical database. Among them, 63 were included 
and compared to 189 matched patients (no PPH). The mean interval time between UAE and this study 
was 8.1 years. Time to menstrual cycle recovery after delivery (3.9 vs 5.6 months, p = 0.66), spotting 
(7.9% vs 7.2%, p = 0.49), dysmenorrhea (25.4% vs 22.2%, p = 0.60) and amenorrhea (14.3% vs 12.2%, 
p = 0.66) were similar between the two groups. There was no difference in the FSFI score between the 
groups (23.2 ± 0.6 vs 23.8 ± 0.4; p = 0.41). However, the interval time to subsequent pregnancy was 
longer for patients after UAE than the control group (35 vs 18 months, p = 0.002). In case of pregnancy 
desire, the success rate was lower after UAE compared to controls (55% vs 93.5%, p < 0.001). The rate 
of PPH was higher in those with previous PPH (6.6% vs 36.4%, p = 0.010). Patients treated by UAE 
for PPH did not report higher rates of gynecological symptoms or sexual dysfunction compared to 
patients with uneventful deliveries. The inter‑pregnancy interval was increased and the success rate 
was reduced. In subsequent pregnancies, a higher rate of PPH was observed in those that underwent 
UAE.
Abbreviations
UAE  Uterine artery embolization
PPH  Postpartum hemorrhage
Postpartum hemorrhage (PPH) remains one of the major causes of maternal morbidity and mortality worldwide. 
The World Health Organization estimates that postpartum hemorrhage accounts for 25% of all maternal  deaths1. 
Most cases of PPH are resolved by fundal massage and uterotonic medications, but major bleeding may require 
second line procedures, such as pelvic artery embolization, uterine tamponade or peripartum hysterectomy as 
lifesaving  options2. The goal of UAE in the context of PPH is to occlude temporarily blood vessels with an absorb-
able material to control  bleeding3. Even though arterial embolization requires equipment and an interventional 
radiologist, some national guidelines (such in France) recommend embolization as a therapy after failure of 
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medical treatment for PPH in cases of stable maternal haemodynamics. Indeed, in a large retrospective study 
including 251 patients, Lee et al. found that UAE was successful in arresting the bleeding in 86.5% of the cases. 
However, temporary blood vessel occlusion may induce local necrosis and inflammatory reactions, with potential 
subsequent adverse effects on the endometrium and ovaries, leading to a disturbance of the menstrual cycle and 
 fertility4,5. Cases of partial or total uterine necrosis after UAE for PPH have also been  described6,7. Nevertheless, 
it is considered to be a safe and effective alternative to surgery, but there are still concerns about the long term 
consequences of UAE on women’s health. A recent systematic review has described gynecological and obstetri-
cal adverse outcomes after UAE for PPH, but most of the studies were limited in power, based on short term 
evaluations or not reporting a control group for comparisons. More, there is no study reporting sexual function 
after UAE with validated  questionnaire8.
The aim of the present study was to evaluate long-term gynecological, sexual and reproductive outcomes for 
patients who underwent UAE for PPH in comparison to a control group of patients without PPH.
Materials and methods
This case control study was designed using our obstetrical database at the University Maternity Hospital, Laus-
anne, Switzerland, which is a referral hospital in the region of the French part of Switzerland for PPH. All data 
were collected prospectively at the time of delivery by the obstetrician or midwife. We previously cross-checked 
our database, with confirmation of congruent data in > 98% of  cases9.
For each delivery in our institution, graduated collector bags were placed just after birth, left in place at least 
for 15 min, and then until the birth attendant judged that bleeding had stopped.
Management of PPH followed national guidelines with manual exploration of the uterus, visual assessment 
of genital tract, bladder indwelling catheter, uterine massage and use of a uterotonic (syntocinon followed by 
sulprostone). Blood transfusions were performed when there was clinical evidence of inadequate oxygen-carrying 
capacity or an haemoglobin concentration < 70 g/l. Fresh frozen plasma was transfused in the presence of con-
sumption coagulopathy and persistent bleeding. If these local measures were unlikely to control the hemorrhage, 
UAE was then considered both after vaginal or caesarean delivery.
Amount of blood loss was recorded in the medical file. We used classical definition of PPH (blood loss of 
500 ml or more after delivery) to identify first eligible women in the study, and then patients who were treated 
with UAE were included. Cases were compared to a group control, which included deliveries that were not 
complicated with PPH, and thus who did not experience UAE. Cases were matched in a 1 to 3 ratio by maternal 
age, parity, ethnicity, year and mode of delivery, birth weight and gestational age. Deliveries that occurred at 
a gestational age less than 24 weeks of gestation or which requested peripartum-hysterectomy were excluded 
from the database.
The current home address of these women was identified using the telephone directory. One of the authors 
attempted to contact all the patients directly by telephone. Patients were informed about the study and included 
after their consent. Current social, demographic, and physical characteristics were registered.
Patients were asked about gynecological symptoms, such as time to return to menstrual cycles, menstrual 
characteristics (quantity, dysmenorrhea), modification of cycles, contraception, pelvic pain and potential gyneco-
logic interventions after the index pregnancy. Patients were also questioned about desire for subsequent preg-
nancy and attempts to conceive. Data of the subsequent following pregnancy were recorded: date of pregnancy, 
pregnancy outcome (miscarriage/livebirth), mode of delivery, gestational age at birth, infant birth weight, recur-
rence of PPH and need for blood product transfusion. Regarding the sexual dysfunction, the Female Sexual 
Function Index (FSFI) questionnaire was sent to patients. This Index has a high reliability and validity and is 
validated in  French10,11. This multidimensional score combines 19 questions in six subscales (desire, arousal, 
lubrication, orgasm, satisfaction, and pain). The score ranges from 2 to 36, with high scores representing high 
sexual activity and satisfaction and low scores signifying sexual difficulties or little sexual activity. Both groups 
received the same questionnaires by phone and by mail. The study was approved by the Ethical Committee of the 
University and Hospital Lausanne, Switzerland (protocol 55/13; date of approval 07.16.2013). We confirm that 
all methods were performed in accordance with the relevant guidelines and regulations, and informed consent 
was obtained from all participants.
Statistical analyses. Demographic data and patient responses were compared between the case and con-
trol groups using the Pearson χ2 test (or the Fisher’s exact test when indicated) for categorical variables. For 
continuous variables, means were compared by the Student’s t test. Statistical analyses were performed using 
STATA-15 (Stata Corporation, College Station, USA).
Results
From 2003 to 2013, 27,344 women delivered in our institution. Among them, 875 (3.2%) had a PPH and 77 
(0.2%) underwent UAE. A total of 12 women were lost to follow-up and 2 declined to participate. The 63 remain-
ing cases were compared to 189 women without PPH who were matched by age, parity, ethnicity, year and mode 
of delivery, birth weight and gestational age. Sociodemographic and index delivery characteristics of women 
with and without UAE were similar (Table 1). The mean interval between the index delivery and response to the 
questionnaires was 8.1 years [95% CI 7.8–8.4].
Gynecological outcomes. Time to return of menstrual cycles in patients with UAE was shorter than those 
without UAE (Table 2), without reaching significance (3.9 versus 5.2 months; p = 0.066). Menstrual cycle dis-
turbances such as amenorrhea, dysmenorrhea, and modification of cycles were similar between both groups. 
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Table 1.  socio-demographic characteristics at the index delivery (SD: standard deveiation; min: minutes).
Controls Cases
p valueWithout embolization (n = 189) With embolization (n = 63)
Age (years + SD) 32.6 ± 4.3 32.9 ± 4.7 0.539
Gestational age at birth (weeks + SD) 38.2 ± 2.8 37.8 ± 2.9 0.594
Birth weight at index pregancy (gr + SD) 3076 ± 714 2874 ± 825 0.136
Arterial pH < 7.1 5 (2.7%) 0 (0%) 0.192
Apgar < 7at 5 min 8 (4.2%) 2 (3.2%) 0.709
Parity
1 46 (24.4%) 23 (36.5%) 0.155
2 87 (46.0%) 26 (41.3%)
>3 56 (29.6%) 14 (22.2%)
Nationality
Swiss citizen 86 (45.5%) 23 (36.5%) 0.212
Non swiss 103 (54.5%) 40 (63.5%)
Table 2.  Gynecological outcomes (95% CI; 95% confidence intervals).
Controls Cases
p valueWithout embolization n = 189 (%) With embolization n = 63 (%)
Menses after delivery, months [95% CI] 5,7 [4.6–6.9] 3.9 [2.9–4.9] 0.066
Hormonal contraception 101 (53.4%) 30 (47.6%) 0.423
Gynecological surgery 13 (6.9%) 6 (9.5%) 0.491
Menstrual disturbance
Amenorrhea 23 (12.2%) 9 (14.3%) 0.662
Dysmenorrhea 42 (22.2%) 16 (25.4%) 0.604
Spotting 14 (7.4%) 5 (7.9%) 0.496
Modified cycle 80 (42.3%) 27 (42.9%) 0.866
Figure 1.  pregnancy desire and pregnancy outcomes, control patients.
4
Vol:.(1234567890)
Scientific Reports |          (2021) 11:833  | https://doi.org/10.1038/s41598-020-80821-0
www.nature.com/scientificreports/
About half of the patients were using hormonal contraception at the time of the questionnaire. The rate of any 
subsequent gynecological surgery after the index delivery was similar between both groups.
Sexual dysfunction. There was no difference in the mean total score of the FSFI between patients with 
and without UAE for PPH. More, for each subscale item, the score was similar, except for “pain during vaginal 
penetration about half of the time or more” (21.1% in the UAE group vs 7.8% in the control group, p = 0.027). 
Table 3 sums up sexual dysfunction with the FFSI score.
Reproductive outcomes. The rate of women who planned to have another pregnancy after the index 
pregnancy (Table 4) was similar between the two groups (33.3% in the UAE group vs 41.8% in the group control, 
p = 0.234). The rate of spontaneous pregnancy for the subsequent pregnancy was not different (100% in the UAE 
group vs 91.1% in the control group, p = 0.206).
Table 3.  Sexual dysfunction.
FSFI questionnaire
Patients Patients
p valueWithout embolization % (n = 104) With embolization % (n = 38)
Sexual desire half of the time or less 17.5 27.8 0.185
Low level of sexual desire 22.3 27.0 0.564
Score "DESIRE" (1.2–6) 4.0 ± 0.1 3.9 ± 0.2 0.560
Excitation during sexual activity half of the time or less 53.9 63.9 0.300
Low level of excitation during sexual activity 42.2 54.1 0.213
Low confidence about becoming sexually excited during 
sexual activity 25.5 24.3 0.889
Satisfied with excitation during sexual activity less than 
half of the time 61.8 59.5 0.805
Score "EXCITATION" (0–6) 3.4 ± 0.1 3.3 ± 0.2 0.825
Lubrication during sexual activity less than half of the 
time 55.9 50.0 0.534
Difficulty becoming lubricated during sexual activity 7.9 10.5 0.626
Maintain lubrication until completion of sexual activity 
less than half of the time 61.8 56.8 0.594
Difficulty maintaining lubrication until completion of 
sexual activity 7.5 12.0 13.2 0.853
Score "LUBRICATION" (0–6) 4.4 ± 0.1 4.4 ± 0.8 0.504
Reach orgasm less than half of the time 24.5 40.5 0.065
Reaching orgasm difficult 12.9 8.1 0.439
Moderatly dissatisfied with ability to reach orgasm 56.9 59.5 0.784
Score "ORGASM" (0–6) 4.0 ± 0.1 3.9 ± 0.1 0.696
Moderatly satisfied with amount of emotional closeness 
during sexual activity 55.9 62.2 0.508
Moderatly dissatisfied about the sexual relationship 58.4 59.5 0.912
Moderatly dissatisfied about overall sexual life 50.0 59.5 0.324
Score "SATISFACTION" (0–6) 2.7 ± 0.1 2.9 ± 0.2 0.694
Pain during vaginal penetration about half of the time or 
more 7.8 21.1 0.027
Pain following vaginal penetration more than half of the 
time 2.9 5.3 0.503
High level of pain during or following vaginal penetration 6.8 15.8 0.101
Score "PAIN" (0–6) 5.1 ± 0.1 5.0 ± 0.2 0.673
Score total (2–36) 23.8 ± 0.4 23.2 ± 0.6 0.412
Table 4.  Desire for and fear of subsequent pregnancy.
Controls Cases
p valueWithout embolization n = 189 (%) With embolization n = 63 (%)
Desire for subsequent pregnancy 77 (41.8%) 20 (33.3%) 0.234
Fear as reason for pregnancy avoidance 9/112 (8.2%) 16/43 (38.1%) < 0.001
Unplanned pregnancy 7 (3.7%) 2 (3.2%) 0.845
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Among patients who pursued another pregnancy (Figs. 1 and 2 should be side by side to be able to be com-
pared), those with UAE were significantly less successful than those without UAE (55.0% versus 93.5%, p < 0.001, 
Table 5). Additionally, a significantly higher time to conception was present in those conceiving after UAE than 
controls (35 versus 18 months, p = 0.002). The arguments put forward by patients to justify this delay were mainly 
Figure 2.  pregnancy desire and pregnancy outcomes of embolized patients (UAE).
Table 5.  Fertility outcomes among patients with interest in subsequent pregnancy (95% CI: 95% confidence 
intervals).
Controls Cases
p valueWithout embolization n = 189 (%) With embolization n = 63 (%)
Interval to next pregnancy, months [95% CI] 18 [14–22] 35 [21–50] 0.002
Pregnancy obtained 72/77 (93.5%) 11/20 (55%) < 0.001
Pregancy desired but not attempted at the time of the 
questionnaire 1/77 (1.3%) 7/20 (35%) < 0.001
Secondary infertility 4/77 (5.2%) 2/20 (10%) 0.427
Infertility investigation 11/77 (14.4%) 0/20 (0%) 0.180
Spontaneous pregnancies 72/79 (91.1%) 13/13(100%) 0.206
Table 6.  Subsequent pregnancy outcomes (for patients who became pregnant after the index pregnancy). Only 
the first pregnancy after the index pregnancy is described below.
Controls Cases
p valueWithout embolization n=189 (%) With embolization n=63 (%)
First trimester miscarriage 11 (13.9%) 1 (7.7%) 0.79
Pregnancy termination 4 (4.3%) 1 (7.7%) 1
Extra-uterine pregnancy 3 (3.8%) 0 (0%) 0.575
Spontaneous vaginal birth 40/61 (65.6%) 4/11 (36.4%) 0.67
PPH 4/61 (6.6%) 4/11 (36.4%) 0.015
Birth weight of 1st pregnancy after the index pregnancy 
(gr + SD) 3224 + 602 3083 + 453 0.461
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the fear of a recurrence of PPH. No patient who underwent UAE required an assisted reproductive procedure. 
There was no significant difference in the rate of unplanned pregnancies between the 2 groups. 
Regarding subsequent pregnancy, the rates of spontaneous miscarriages, terminations of pregnancy, and 
ectopic pregnancies were similar between patients with and without UAE (Table 6).
All the remaining pregnancies delivered at  > 37 weeks gestations. The rate of cesarean section was double in 
patients with previous UAE compared to controls, without reaching statistical significance (p = 0.67). The rate of 
PPH was significantly higher in those with previous UAE compared to the controls (36.4% versus 6.6%, p = 0.015).
Birth weight and rate of intra-uterine growth restrictions (IUGR) were similar between both groups. All 72 
children were born healthy.
Discussion
Main findings. This study confirmed the safety of uterine arterial embolization, as it did not find long term 
consequences of common gynecological symptoms and sexual functions. However, women with a previous UAE 
should be appropriately counseled for the risk of recurrence of PPH in a subsequent pregnancy.
Strength and limitations. Many strengths should be underlined. The high rate of eligible women who 
were included is undoubtfully a strength, notably after a long-time frame, over which outcomes were examined 
other than obstetric outcomes making possible a large sample size. Searching for associations between an expo-
sition and an adverse outcome is always challenging, and matching the two groups with several well-known 
cofounders for PPH as maternal age, mode of delivery, gestational age of delivery remains an accepted method 
to answer the question. Nevertheless, some cofounders notably for PPH were not taken into account, as history 
of PPH, use of oxytocin during labor, and caution should be taken in the interpretation of the results. Another 
limitation is the control group. In order to conclude that the reduction in pregnancy rate is due to UAE, it would 
be necessary to compare with and without UAE implementation in the population with previous PPH. Indeed, 
one could also argue that the best controls should be women whose delivery was complicated by PPH and who 
were not treated with UAE. However, our study did not reveal any difference in most of the outcomes examined, 
except for the recurrence of PPH. We can therefore assume that UAE is a safe procedure that does not affect 
occurrence of gynecological symptom or sexual dysfunction compared to women whose delivery was uncom-
plicated by PPH.
Another limitation of our study, as in many studies evaluating long-term maternal outcomes, was the potential 
for recall bias, as mentioned above. Evaluation by a phone interview and questionnaires of an event that occurred 
8 years ago on average can be subjective and depends on the accuracy of patient memory. Finally, we did not 
have an evaluation of baseline symptoms prior to the index delivery. It was thus impossible to know whether 
gynecological symptoms or sexual dysfunction were present prior to the index delivery or whether symptoms 
were attributable to the UAE.
Interpretation. UAE plays a major role in the current management of PPH that fails to respond to other 
conservative treatments. While its short-term benefit is well known (avoid hysterectomy and prevent potential 
maternal death), long-term clinical and psychological outcomes of UAE have been poorly investigated. In addi-
tion to the long-term sequelae induced by psychological stress (sexual dysfunction, fear of another pregnancy), 
UAE may induce transient ischemia of the uterus and potentially alter the patients’ future menstrual cycles and 
fertility. The passage of embolization particles into utero-ovarian anastomoses or ovarian arteries originating 
from the uterine arteries may induce endometrial ischemia altering the implantation success of future fertilized 
eggs or provoke early menopause.
The present study shows that the timing and characteristics of menses and sexuality were not affected by 
management of a prior PPH by UAE. The traumatic experience for the patient, however, lowered interest in a 
subsequent pregnancy. In those patients that underwent UAE and desired a subsequent pregnancy, the success 
rate was lower and a longer inter-pregnancy interval was observed compared to controls without PPH. The 
frequency of miscarriage and IUGR were similar between both groups. Cesarean section and PPH rates were 
higher for patients with previous UAE for PPH than controls.
Gynecological outcomes. We, and others (reviewed  in8) did not identify any change in menstrual cycles 
or gynecological symptoms after UAE. The return of menses was longer in the controls than in patients with 
UAE, although not significant. After PPH, women are less likely to initiate and sustain exclusive  breastfeeding12, 
which may explain this difference, as most mothers who pursue exclusive breastfeeding are amenorrheic for 
3–6 months.
The rate of menstrual cycle disturbances described in the present study was similar to those described by 
others. Sentilhes et al.13 identified a 10.3% risk of synechia diagnosed by hysteroscopy after UAE. In our study, 
data regarding hysteroscopies was not collected and synechia could thus not be excluded in patients with amen-
orrhea or secondary infertility.
Sexual function following UAE can theoretically be affected by two mechanisms. First, entry of embolization 
particles into cervical or vaginal anastomoses might induce local ischemia and thus dyspareunia, lack of lubri-
fication, and denervation. Secondly, psychological and environmental factors can also affect sexual function. A 
life-threatening event could affect the libido of both the patient and partner. As summarized in the Soro et al. 
review, few studies with non-validated questionnaires have evaluated sexual function after UAE and reported 
inconsistent results. Our evaluation using the FSFI questionnaire did not demonstrate major difference between 
patients with and without UAE, in particular for lubrication or dyspareunia. Libido, which is particularly depend-
ent on psychological and environmental factors, was not influenced by the events in the index pregnancy.
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Reproductive outcomes. According to Hardeman et al., the fertility of patients after UAE is lower than the 
general population, without being statistically significant in their  study4. Our study confirms these results with 
a similar secondary infertility rate for patients with UAE compared to controls. Additionally, the time to achieve 
pregnancy is almost doubled for patients with UAE, as also described by Capmas et al.14. While the theory of an 
unfavorable endometrium post-UAE might explain this difference, the psychological impact of the PPH is more 
likely the key factor for this delay.
Of the 20 patients who planed a subsequent pregnancy, 38% had not yet attempted to achieve a pregnancy 
by the time of our present study. This mirrors the results presented by Sentilhes et al.13. Our study highlights 
the underlying reason behind this prolonged interval. Patients who are undecided, are delaying conception and 
those that have opted against a subsequent pregnancy regularly discuss fear of PPH recurrence. These results 
are in line with studies showing that following traumatic childbirth, women with higher levels of posttraumatic 
stress disorder (PTSD) symptoms at six weeks postpartum show an increased likelihood of deciding not to have 
further children; and women after a traumatic birth who do embark on a subsequent pregnancy report delaying 
this longer than those without such an  experience15. Indeed, a PPH meets criteria for a traumatic  stressor16 and it 
is thus likely, that some, if not many participants, perceived their childbirth as traumatic, which is an important 
risk factor for postpartum  PTSD17.
None of the patients with UAE underwent fertility treatment, whereas 14.4% of those in the control group 
pursuing another pregnancy underwent a fertility treatment (half required assistance for their index pregnancy). 
Again, “fear” and having experienced their childbirth as traumatic may explain this difference, as those with a past 
history of requiring UAE for PPH may want to avoid both another PPH as well as any medically related situation.
In our study, we observed a significant difference in the success of achieving a subsequent desired pregnancy 
between cases and controls. Hardman et al., although lacking significance, made similar observations. The psy-
chological impact of PPH is likely underestimated and plays a prominent role in the fertility rate our patients.
Our results support the hypothesis that UAE does not affect future uteroplacental exchange and thus the rates 
of miscarriage, IUGR and preterm birth. However, a previous episode of PPH is a risk factor for its recurrence 
regardless of its initial  management18, as also verified in our study. However, it is unclear whether the risk of 
recurrence of PPH is more related to history of PPH or to PPH treated with UAE. More than one third of the 
patients in this study with PPH and treated with UAE had a recurrence, which is more than the 19.2% described 
by Soro et al.8. Recall bias cannot be excluded in our study, as information regarding subsequent pregnancies 
was obtained via patient questionnaires without access to the official medical records.
In conclusion, our study confirms the safety of UAE for PPH. The long-term effects in women who have 
been treated with UAE for PPH seem limited. Since subsequent pregnancy outcomes after UAE were similar to 
the control group, patients can be reassured during counselling about future pregnancies. Recurrence of PPH, 
however, is increased and subsequent deliveries should be actively managed accordingly. The psychological 
impact of PPH should not be underestimated, and warrants further investigations, as performed in the second 
part of this study. In the management of patients following a UAE, early identification of those experiencing high 
levels of distress and recommendation of psychological counseling or other appropriate interventions should 
be strongly considered.
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